Hyperphosphataemic familial tumoral calcinosis: case report of a rare and challenging disease
Authors:
- 19 June 2019
- journal article
- letter
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 49 (1) , 80-81
Abstract
(2019). Hyperphosphataemic familial tumoral calcinosis: case report of a rare and challenging disease. Scandinavian Journal of Rheumatology. Ahead of Print.Keywords
This publication has 8 references indexed in Scilit:
- Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literatureOsteoporosis International, 2018
- Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia SyndromeJournal of Bone and Mineral Research, 2016
- Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro MineralizationCalcified Tissue International, 2015
- Hyperphosphatemic Familial Tumoral Calcinosis: Genetic Models of Deficient FGF23 ActionCurrent Osteoporosis Reports, 2015
- Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3mutation; case report and review of the literatureBMC Genomic Data, 2014
- Two novel nonsense mutations in GALNT3 gene are responsible for familial tumoral calcinosisJournal of Human Genetics, 2007
- Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindredJournal of Human Genetics, 2006
- PROPOSAL FOR A PATHOGENESIS‐BASED CLASSIFICATION OF TUMORAL CALCINOSISInternational Journal of Dermatology, 1996